Literature DB >> 34337969

Perceptions of the COVID-19 vaccine among patients with cancer: a single-institution survey.

Elissar Moujaess1, Naji Bou Zeid1, Ramy Samaha1, Joud Sawan1, Hampig Kourie1, Chris Labaki1, Roy Chebel1, Georges Chahine1, Fadi El Karak1, Fadi Nasr1, Marwan Ghosn1, Jad Wakim1, Joseph Kattan1.   

Abstract

Aims: This paper reports the results of a survey assessing the acceptance of the coronavirus disease 2019 (COVID-19) vaccine among patients with cancer. Patients and methods: In total, 111 adult patients with cancer from a single institution were asked to complete a questionnaire designed to assess their knowledge about the vaccine, their readiness to be vaccinated and the determinants of their decision.
Results: 61.3% of the patients considered themselves more vulnerable to COVID-19 than the general population. Television, radio and newspapers were the major sources of information about the vaccine. A total of 55% of the patients were ready to be vaccinated and 14.4% refused the vaccine. The main reason for refusal was incompatibility with patients' disease or treatment.
Conclusion: Most of the patients in this institutional sample accepted the COVID-19 vaccine. Better communication of information with patients is needed to decrease vaccine hesitancy.

Entities:  

Keywords:  COVID-19; acceptance; cancer; hesitancy; survey; vaccine

Year:  2021        PMID: 34337969      PMCID: PMC8328088          DOI: 10.2217/fon-2021-0265

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  17 in total

1.  Priority COVID-19 Vaccination for Patients with Cancer while Vaccine Supply Is Limited.

Authors:  Antoni Ribas; Rajarshi Sengupta; Trevan Locke; Sayyed Kaleem Zaidi; Katie M Campbell; John M Carethers; Elizabeth M Jaffee; E John Wherry; Jean-Charles Soria; Gypsyamber D'Souza
Journal:  Cancer Discov       Date:  2020-12-19       Impact factor: 38.272

2.  The impact of the coronavirus pandemic on the management of cancer patients in Lebanon: a single institutional experience.

Authors:  Clarisse Kattan; Hassan Badreddine; Elie Rassy; Hampig Raphael Kourie; Joseph Kattan
Journal:  Future Oncol       Date:  2020-04-23       Impact factor: 3.404

3.  Knowledge, Perceptions, and Attitude of Egyptians Towards the Novel Coronavirus Disease (COVID-19).

Authors:  Ahmed Samir Abdelhafiz; Zeinab Mohammed; Maha Emad Ibrahim; Hany H Ziady; Mohamed Alorabi; Mohamed Ayyad; Eman A Sultan
Journal:  J Community Health       Date:  2020-10

4.  Vaccine confidence in the time of COVID-19.

Authors:  Emily A Harrison; Julia W Wu
Journal:  Eur J Epidemiol       Date:  2020-04-22       Impact factor: 8.082

5.  Attitudes Toward a Potential SARS-CoV-2 Vaccine : A Survey of U.S. Adults.

Authors:  Kimberly A Fisher; Sarah J Bloomstone; Jeremy Walder; Sybil Crawford; Hassan Fouayzi; Kathleen M Mazor
Journal:  Ann Intern Med       Date:  2020-09-04       Impact factor: 25.391

6.  Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.

Authors:  Fernando P Polack; Stephen J Thomas; Nicholas Kitchin; Judith Absalon; Alejandra Gurtman; Stephen Lockhart; John L Perez; Gonzalo Pérez Marc; Edson D Moreira; Cristiano Zerbini; Ruth Bailey; Kena A Swanson; Satrajit Roychoudhury; Kenneth Koury; Ping Li; Warren V Kalina; David Cooper; Robert W Frenck; Laura L Hammitt; Özlem Türeci; Haylene Nell; Axel Schaefer; Serhat Ünal; Dina B Tresnan; Susan Mather; Philip R Dormitzer; Uğur Şahin; Kathrin U Jansen; William C Gruber
Journal:  N Engl J Med       Date:  2020-12-10       Impact factor: 91.245

7.  The ESMO Call to Action on COVID-19 vaccinations and patients with cancer: Vaccinate. Monitor. Educate.

Authors:  M C Garassino; M Vyas; E G E de Vries; R Kanesvaran; R Giuliani; S Peters
Journal:  Ann Oncol       Date:  2021-02-12       Impact factor: 32.976

8.  COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses.

Authors:  Ugur Sahin; Alexander Muik; Evelyna Derhovanessian; Isabel Vogler; Lena M Kranz; Mathias Vormehr; Alina Baum; Kristen Pascal; Jasmin Quandt; Daniel Maurus; Sebastian Brachtendorf; Verena Lörks; Julian Sikorski; Rolf Hilker; Dirk Becker; Ann-Kathrin Eller; Jan Grützner; Carsten Boesler; Corinna Rosenbaum; Marie-Cristine Kühnle; Ulrich Luxemburger; Alexandra Kemmer-Brück; David Langer; Martin Bexon; Stefanie Bolte; Katalin Karikó; Tania Palanche; Boris Fischer; Armin Schultz; Pei-Yong Shi; Camila Fontes-Garfias; John L Perez; Kena A Swanson; Jakob Loschko; Ingrid L Scully; Mark Cutler; Warren Kalina; Christos A Kyratsous; David Cooper; Philip R Dormitzer; Kathrin U Jansen; Özlem Türeci
Journal:  Nature       Date:  2020-09-30       Impact factor: 49.962

9.  Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated?

Authors:  Paul L Reiter; Michael L Pennell; Mira L Katz
Journal:  Vaccine       Date:  2020-08-20       Impact factor: 3.641

10.  WHO Declares COVID-19 a Pandemic.

Authors:  Domenico Cucinotta; Maurizio Vanelli
Journal:  Acta Biomed       Date:  2020-03-19
View more
  9 in total

1.  Knowledge and Proportion of COVID-19 Vaccination and Associated Factors Among Cancer Patients Attending Public Hospitals of Addis Ababa, Ethiopia, 2021: A Multicenter Study.

Authors:  Fitalew Tadele Admasu
Journal:  Infect Drug Resist       Date:  2021-11-23       Impact factor: 4.003

2.  Solid cancer patients achieve adequate immunogenicity and low rate of severe adverse events after SARS-CoV-2 vaccination.

Authors:  Urska Janzic; Urska Bidovec-Stojkovic; Katja Mohorcic; Loredana Mrak; Nina Fokter Dovnik; Marija Ivanovic; Maja Ravnik; Marina Caks; Erik Skof; Jerneja Debeljak; Peter Korosec; Matija Rijavec
Journal:  Future Oncol       Date:  2022-06-09       Impact factor: 3.674

3.  Cancer Patient-Reported Experience Measures (PREMs) Regarding the Policies Implemented to Contain the Spread of Sars-CoV-2 and Vaccination Campaign at Veneto Institute of Oncology.

Authors:  Mario Caccese; Silvia Imbevaro; Alessandra Feltrin; Daniela Costardi; Nadia Giordano; Maristella Maran; Rosalba Martino; Ketti Ottolitri; Malihe Shams; Federica Vascon; Anna Roma; Antonella Galiano; Marco Maruzzo; Dario Marino; Giuseppe Lombardi; Sara Lonardi; Antonella Brunello; Vittorina Zagonel
Journal:  Patient Prefer Adherence       Date:  2022-02-09       Impact factor: 2.711

4.  Short term safety of coronavirus disease 2019 vaccines in patients with solid tumors receiving systemic therapy.

Authors:  Ronald E Cox; Marie Parish; Carolyn Oxencis; Edward Mckenna; Bicky Thapa; Sakti Chakrabarti
Journal:  World J Clin Oncol       Date:  2022-07-24

5.  An update on the impact of SARS-CoV-2 pandemic public awareness on cancer patients' COVID-19 vaccine compliance: Outcomes and recommendations.

Authors:  Lina Souan; Maher A Sughayer; Maha Abu Alhowr; Khawlah Ammar; Sara Al Bader
Journal:  Front Public Health       Date:  2022-07-22

6.  From a voluntary vaccination policy to mandatory vaccination against COVID-19 in cancer patients: an empirical and interdisciplinary study in bioethics.

Authors:  Henri-Corto Stoeklé; Sakina Sekkate; Philippe Beuzeboc; Christian Hervé; Elisabeth Angellier; Titouan Kennel; Asmahane Benmaziane; May Mabro; Jean-François Geay
Journal:  BMC Med Ethics       Date:  2022-08-28       Impact factor: 2.834

7.  Acceptance, effects, and tolerability in the vaccination process against SARS-CoV-2 among cancer patients in Bosnia and Herzegovina: A single-center cross-sectional study.

Authors:  Timur Cerić; Emir Sokolović; Anes Pašić; Emina Borovac-Gurda; Velda Smajlbegović; Berisa Hasanbegović; Emina Bičakčić Filipović; Elma Kapisazović; Selma Sokolović; Semir Bešlija
Journal:  Bosn J Basic Med Sci       Date:  2022-09-16       Impact factor: 3.759

8.  Individual-level factors associated with COVID-19 vaccine acceptance among U.S. patients with cancer.

Authors:  Cassandra A Hathaway; Erin M Siegel; Brian D Gonzalez; Laura B Oswald; Anita R Peoples; Cornelia M Ulrich; Frank J Penedo; Shelley S Tworoger; Jessica Y Islam
Journal:  Vaccine       Date:  2022-09-28       Impact factor: 4.169

Review 9.  COVID-19 vaccine acceptance and hesitancy among patients with cancer: a systematic review and meta-analysis.

Authors:  K I P Prabani; I Weerasekara; H D W T Damayanthi
Journal:  Public Health       Date:  2022-09-08       Impact factor: 4.984

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.